Attending Society for Neuroscience 2024 in Chicago!

Once again I’ll be making the trip out to the annual Society for Neuroscience meeting! Come check out the posters with my students and collaborators!

New NIH-funded UH3 to study the use of Deep Brain Stimulation to treat those with Bipolar Depression

I’m happy to announce that in collaboration with Drs. Wayne Goodman and Sameer Sheth of Baylor College of Medicine, the NIH has decided to fund our proposed study examining the use of deep brain stimulation to treat Bipolar Depression. More information will be coming soon, but in the meantime, the basics of the proposal are on NIH Reporter.

There is also an announcement of the project by the Baylor College of Medicine team here.

New paper detailing the impact of data processing choices on evoked potentials

GridLab neuroscience PhD student Lila Levinson authored a paper breaking down the impact of signal pre-processing decisions on commonly discussed metrics of evoked potentials, highlighting how the lack of standardization of processing techniques can lead to inconsistent results across different groups. The paper was recently published in the Journal of Neuroscience Methods and can be found here.

Attending the 10th Annual BRAIN Initiative Meeting and presenting a development update with the CorTec Brain Interchange

I’ll be attending the annual BRAIN Initiative Meeting in Washington DC this coming weekend to present our group’s ongoing development progress with the CorTec Brain Interchange to support our upcoming stroke study. The poster is accessible via this link. Also check out the OpenMind Consortium’s poster detailing the impact of our ongoing technological dissemination efforts!

Research progress being presented at 2024 American Society for Stereotactic and Functional Neurosurgery Meeting

My Bioengineering PhD Student Raphael Bechtold and collaborators from Baylor College of Medicine are all heading to Nashville for the 2024 American Society for Stereotactic and Functional Neurosurgery Meeting to present our ongoing work studying the use of neuromodulation therapies for neuropsychiatric disorders! Check out their work –

  • Bechtold, N. Provenza, N. Giridharan, A. Allam, S. Rajesh, A. Gandhi, G. Reyes, S. Reddy, E. Storch, S. A. Sheth, W. K. Goodman, and J. Herron, “Offline simulation of adaptive deep brain stimulation algorithm classification for performance characterization during provocation of OCD symptoms
  • Giridharan, N. Provenza, A. Allam, R. Bechtold, N. Diab, S. Rajesh, S. Reddy, G. Reyes, E. Dastin-van Rijn, A. Gandhi, S. Hirani, H. Dang, G. Banks, M. Avendano-Ortega, S. McKay, D. Borton, E. Storch, J. Herron, W. Goodman, S. Sheth “Low-Frequency Power in The Ventral Capsule/Ventral Striatum and Orbitofrontal Cortex: A Neural Biomarker of Obsessive-Compulsive Symptom Severity
  • Provenza, G. Reyes, K, Katlowitz, R. Bechtold, N. Diab, S. Reddy, A. Allam, A. Gandhi, S. Hirani, N. Giridharan, G. Banks, M. Hasen, B. Shofty, B. Hayden, J. Cohn, E. Storch, J. Herron, M. Phillips, W. Goodman, S. Sheth “Deep Brain Stimulation of the Ventral Capsule and Ventral Striatum Drives Approach Behavior and High Beta Power in Ventrolateral Prefrontal Cortex
  • Provenza, S. Reddy, A. Allam, S. Rajesh, N. Diab, R. Caston, K. Katlowitz, A. Gandhi, H. Dang, R. Najera, N. Giridharan, F. Momin, M. Hasen, G. Banks, B. Shofty, B. Hayden, J. Herron, E. Storch, A. Patel, W. Goodman, S. Sheth “DBS Disruption of Neural Rhythms Predicts Shifts in Clinical Response in Obsessive-Compulsive Disorder”
  • Kang, W. Mahaphanit, N. Provenza, M. Nassar, A. Allam, R. Bechtold, N. Diab, S. Rajesh, S. Reddy, G. Reyes, E. Dastin-van Rijn, A. Gandhi, S. Hirani, G. Banks, H. Dang, M. Avendano-Ortega, S. McKay, D. Borton, M. Frank, E. Storch, J. Herron, W. Goodman, B. Hayden, S. Sheth “The Effect of Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder in Cognitive Self-Control Under Uncertainty

FDA approves our Investigational Device Exemption for an Early Feasibility Study to rehabilitate stroke patients using CorTec’s Closed-Loop Brain Interchange implant system

We are excited to announce that the FDA approved our Investigational Device Exemption application to make use of the CorTec Brain Interchange in a study seeking to enhance stroke rehabilitation through the use of neuroplasticity-inducing stimulation! Pending IRB approval, we will be seeking individuals with persistent upper limb disability following stroke to participate in this first-of-it’s-kind study with this new device. More information will be coming soon, and for more information check out CorTec’s press release here.